Thyroid Function Test Market Report
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
This report, from Stratview Research, studies the clinical diagnostics market - thyroid function testing over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Burning Questions This Report Will Answer:
The highly prescribed and sensitive thyrotropin (TSH) and free thyroid hormone measurements (free T3 and T4) by endocrinologist suspecting thyroid gland malfunctioning, have made interpretation of thyroid function relatively simpler, but there are occasions where the pattern is confusing or misleading.
Change in the pattern of thyroid hormone are usually seen in emergency patients with no known thyroid dysfunction. A decrease in triiodothyronine (T3) has been observed with normal levels of free thyroxine (fT4) and thyroid-stimulating hormone (TSH), a condition commonly known in medical science as euthyroid sick syndrome (ESS) or non-thyroidal illness syndrome (NTIS), or low T3 syndrome. Medically, thyroid hormone changes are believed to be physiological adaptations owing to re-allocation and metabolism of body energy caused by an acute illness. Therefore, in many cases, thyroid hormone levels return to normal once the illness or stress condition is overcome.
The market has few players and is considered niche. Companies such as Thermo Fisher (US), Abbott (US), Roche (Switzerland), DiaSorin (Italy), Danaher (US), Kronus (US), Merck (Germany), Cortez Diagnostics (US), bioMérieux (France), Qualigen (US), and Autobio Diagnostics (China) play a significant role in the market.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
The global clinical diagnostics market (thyroid function testing) is segmented into the following categories:
By Testing Facility
With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].